IP Library › Assignment 014787/0286
Patent Assignment
Reel/Frame 014787/0286

Change of Name

Recorded: 2004-06-28 Pages: 3
Assignor
Assignee
AVENTIS PHARMACEUTICALS INC.
300 SOMERSET CORPORATE BOULEVARD, BRIDGEWATER, NEW JERSEY, 08807-2854
Covered Property (1)
Quinoline and Quinoxaline Compounds Which Inhibit Platelet-Derived Growth Factor and/or P56LCK Tyrosine Kinases
Patent: 6,852,712 →
Application: 10/357,882 →
Publication: US 2003/0139399
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 25, 2004
From: MYERS, MICHAEL R.; HE, WEI; SPADA, ALRED P.; MAGUIRE, MARTIN P.
To: RHONE-POULENC RORER PHARMACEUTICALS, INC.
Reel/Frame 014783/0605 →
Change of Name Jun 28, 2004
From: RHONE-POULENC RORER PHARMACEUTICALS INC.
To: AVENTIS PHARMACEUTICALS PRODUCTS INC.
Reel/Frame 014784/0928 →
Change of Name May 18, 2006
From: AVENTIS PHARMACEUTICALS PRODUCTS INC.
To: AVENTIS PHARMACEUTICALS INC.
Reel/Frame 017636/0360 →